162 related articles for article (PubMed ID: 856237)
41. Effect of hyperthermia on hypoxic cell fraction in tumor.
Song CW; Rhee JG; Levitt SH
Int J Radiat Oncol Biol Phys; 1982 May; 8(5):851-6. PubMed ID: 7107420
[TBL] [Abstract][Full Text] [Related]
42. Selective radiosensitization of the hypoxic cells of mouse tumors with the nitroimidazoles metronidazole and Ro 7-0582.
Brown JM
Radiat Res; 1975 Dec; 64(3):633-47. PubMed ID: 1197663
[No Abstract] [Full Text] [Related]
43. A comparative investigation of nimorazole and misonidazole as hypoxic radiosensitizers in a C3H mammary carcinoma in vivo.
Overgaard J; Overgaard M; Nielsen OS; Pedersen AK; Timothy AR
Br J Cancer; 1982 Dec; 46(6):904-11. PubMed ID: 7150484
[TBL] [Abstract][Full Text] [Related]
44. Effect of hypoxia and acidosis on the cytotoxicity of four platinum complexes at normal and hyperthermic temperatures.
Herman TS; Teicher BA; Collins LS
Cancer Res; 1988 May; 48(9):2342-7. PubMed ID: 3356002
[TBL] [Abstract][Full Text] [Related]
45. Effect of pH, oxygenation, and temperature on the cytotoxicity and radiosensitization by etanidazole.
Teicher BA; Herman TS; Holden SA
Int J Radiat Oncol Biol Phys; 1991 Apr; 20(4):723-31. PubMed ID: 1825994
[TBL] [Abstract][Full Text] [Related]
46. Radiosensitization of hypoxic tumor cells by simultaneous administration of hyperthermia and nitroimidazoles.
Hofer KG; Hofer MG; Ieracitano J; McLaughlin WH
Radiat Res; 1977 May; 70(2):362-77. PubMed ID: 860011
[No Abstract] [Full Text] [Related]
47. Conductive thermal ablation of 4T1 murine breast carcinoma reduces severe hypoxia in surviving tumour.
Przybyla BD; Shafirstein G; Koonce NA; Webber JS; Griffin RJ
Int J Hyperthermia; 2012; 28(2):156-62. PubMed ID: 22335229
[TBL] [Abstract][Full Text] [Related]
48. An in vitro and in vivo screening system for new hypoxic cell radiosensitizers using EMT6 cells.
Shibamoto Y; Ono K; Takahashi M; Kano E; Hori H; Shibata T; Inayama S; Abe M
Jpn J Cancer Res; 1986 Oct; 77(10):1027-33. PubMed ID: 3096918
[TBL] [Abstract][Full Text] [Related]
49. Interaction with hyperthermia of tetrachloroplatinum(II)(Nile blue)2 and tetrachloroplatinum(II)(neutral red)2 in EMT6 murine cells and the murine FSaIIC fibrosarcoma.
Herman TS; Teicher BA; Pfeffer MR; Khandekar VS; Korbut TT
Cancer Res; 1990 Jul; 50(13):3826-31. PubMed ID: 2354434
[TBL] [Abstract][Full Text] [Related]
50. The demonstration of in vivo misonidazole tumour toxicity using post radiation hypoxia.
Gomer CJ; Johnson RJ; Hetzel FW; Lawrence G
Br J Cancer Suppl; 1978 Jun; 3():228-31. PubMed ID: 277234
[TBL] [Abstract][Full Text] [Related]
51. Effects of RSR13 and oxygen on the cytotoxicity of cisplatin and carboplatin to EMT6 mouse mammary tumor cells in vitro and in vivo.
Donnelly ET; Kelley M; Rockwell S
Cancer Chemother Pharmacol; 2004 Jan; 53(1):43-50. PubMed ID: 14574460
[TBL] [Abstract][Full Text] [Related]
52. Hypoxic cell radiosensitizers and local control by X-ray of a transplanted tumour in mice.
Sheldon PW; Hill SA
Br J Cancer; 1977 Jun; 35(6):795-808. PubMed ID: 871367
[TBL] [Abstract][Full Text] [Related]
53. In vivo cytotoxicity of misonidazole and hyperthermia in a transplanted mouse mammary tumor.
Lehman CM; Stewart JR
Radiat Res; 1983 Dec; 96(3):628-34. PubMed ID: 6657927
[TBL] [Abstract][Full Text] [Related]
54. Effect of 1-methyl-5-sulfonamide-4-nitroimidazole and 1-methyl-5-bromide-4-nitroimidazole on the radiosensitivity of EMT6 tumor cells.
Rockwell S; Irvin CG; Nierenburg M
Cancer Treat Rep; 1986 Mar; 70(3):411-3. PubMed ID: 3955554
[TBL] [Abstract][Full Text] [Related]
55. [Effect of the hypoxic cell radiosensitizer,a dinitroimidazole derivative, on murine tumors].
Tanaka M; Nakajima T; Fukuda H; Kida A; Tsumura M; Sakashita M; Onoyama Y
Nihon Igaku Hoshasen Gakkai Zasshi; 1986 Dec; 46(12):1442-3. PubMed ID: 3822789
[No Abstract] [Full Text] [Related]
56. Combined use of radioprotective and radiosensitizing drugs in experimental radiotherapy.
Yuhas JM; Yurconic M; Kligerman MM; West G; Peterson DF
Radiat Res; 1977 May; 70(2):433-43. PubMed ID: 193145
[No Abstract] [Full Text] [Related]
57. The response of EMT6 tumor spheroids to combined treatment with misonidazole and either nitrogen mustard, adriamycin, or BCNU.
Twentyman PR
Cancer Clin Trials; 1980; 3(3):253-6. PubMed ID: 7438322
[TBL] [Abstract][Full Text] [Related]
58. Effects of local hyperthermia on the pharmacokinetics of misonidazole in the anaesthetized mouse.
Honess DJ; Workman P; Morgan JE; Bleehen NM
Br J Cancer; 1980 Apr; 41(4):529-40. PubMed ID: 7387851
[TBL] [Abstract][Full Text] [Related]
59. Tumour-specific enhancement of thermoradiotherapy at mild temperatures by the vascular targeting agent 5,6-dimethylxanthenone-4-acetic acid.
Murata R; Horsman MR
Int J Hyperthermia; 2004 Jun; 20(4):393-404. PubMed ID: 15204520
[TBL] [Abstract][Full Text] [Related]
60. Contrasting regrowth delay responses of a murine tumour to isocurative hyperthermia or X irradiation.
Walker A; Wheldon TE; Brunton GF; Abdelaal AS
Br J Radiol; 1982 Oct; 55(658):780-2. PubMed ID: 7127032
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
